Navinta Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NAVINTA LLC, and what generic and branded alternatives to NAVINTA LLC drugs are available?
NAVINTA LLC has sixteen approved drugs.
Summary for Navinta Llc
US Patents: | 0 |
Tradenames: | 15 |
Ingredients: | 15 |
NDAs: | 16 |
Drug Master File Entries: | 25 |
Drugs and US Patents for Navinta Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Navinta Llc | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211251-001 | Jan 16, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Navinta Llc | FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 212957-002 | Aug 20, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Navinta Llc | FOMEPIZOLE | fomepizole | INJECTABLE;INJECTION | 078537-001 | Mar 6, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Navinta Llc | BENZTROPINE MESYLATE | benztropine mesylate | INJECTABLE;INJECTION | 091525-001 | Feb 5, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Navinta Llc | CARMUSTINE | carmustine | INJECTABLE;INJECTION | 210179-001 | Sep 11, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Navinta Llc | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 214363-001 | Oct 8, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Navinta Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 078601-003 | Jul 17, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.